This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
The Zacks Analyst Blog Highlights Molson Coors, CenterPoint Energy, WEC Energy, Abbott Laboratories and HCA Healthcare
by Zacks Equity Research
Molson Coors, CenterPoint Energy, WEC Energy, Abbott Laboratories and HCA Healthcare are included in this Analyst Blog.
Here's Why HCA Healthcare (HCA) is a Strong Growth Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Take the Zacks Approach to Beat the Markets: PhenixFIN, Palomar, Monster Beverage in Focus
by Santanu Roy
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
5 Defensive Stocks to Buy for a Safe Portfolio Amid Tariff-Led Mayhem
by Nalak Das
Five defensive stocks to buy at this soaring volatility are TAP, CNP, WEC, BSX, HCA.
Scoop Up These 3 GARP Stocks to Receive Handsome Returns
by Vasundhara Sawalka
The GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount. HCA, NFG and BGC are some such stocks.
The Zacks Analyst Blog Highlights Mastercard, Medtronic, HCA Healthcare and United Homes
by Zacks Equity Research
Mastercard, Medtronic, HCA Healthcare and United Homes are part of the Zacks top Analyst blog.
Has HCA Healthcare (HCA) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Here is how HCA Healthcare (HCA) and Brookdale Senior Living (BKD) have performed compared to their sector so far this year.
Top Stock Reports for Mastercard, Medtronic & HCA Healthcare
by Mark Vickery
Today's Research Daily features new research reports on 12 major stocks, including Mastercard Incorporated (MA), Medtronic plc (MDT) and HCA Healthcare, Inc. (HCA), as well as a micro-cap stock United Homes Group, Inc. (UHG).
Earnings Growth & Price Strength Make HCA Healthcare (HCA) a Stock to Watch
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
Community Health Rides on Same-Store Volumes, Streamlining Efforts
by Zacks Equity Research
With improving labor trends, CYH's contract labor expenses are decreasing.
Tenet Healthcare Gains 26.9% in a Year: Is It the Right Time to Invest?
by Zacks Equity Research
THC benefits from rising admissions, improved payer mix and deleveraging initiatives.
Why HCA Healthcare (HCA) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Universal Health Stock Down 26.6% in 6 Months: Should You Buy the Dip?
by Zacks Equity Research
UHS' rising admissions and patient days poise its top line well for growth in the future.
Here's Why HCA Healthcare (HCA) is a Strong Momentum Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
New to Investing? This 1 Medical Stock Could Be the Perfect Starting Point
by Zacks Equity Research
The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
3 Sector ETFs & Stocks to Gain Despite Downbeat February Jobs Data
by Sanghamitra Saha
These sectors added decent jobs in February when the U.S. economy added fewer-than-expected jobs.
The Joint Gears Up for Q4 Earnings: Here's What to Expect
by Zacks Equity Research
JYNT's fourth-quarter results are likely to reflect higher Royalty fees, Software fees and Advertising fund revenues.
Why This 1 Medical Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why HCA Healthcare (HCA) is a Strong Value Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Acadia Healthcare Q4 Earnings Miss on Reduced Length of Stay
by Zacks Equity Research
ACHC expects revenues to be between $3.3 billion and $3.4 billion in 2025.
Tenet Healthcare's Cheaper Valuation: A Hidden Gem in Healthcare?
by Kaibalya Pravo Dey
THC is strengthening its focus on ASCs to tap into the growing demand for outpatient services.
Teladoc Health Q4 Loss Widens on Soft Integrated Care Unit
by Zacks Equity Research
TDOC expects revenues in the Integrated Care segment to witness 0-3% growth on a year-over-year basis.
Universal Health Q4 Earnings Beat on Strong Adjusted Admissions
by Zacks Equity Research
UHS' fourth-quarter earnings benefit from rising admissions and patient days. Higher expenses partially offset the positives.